Predicting the in vitro toxicity of synthetic beta-amyloid (1-40)

Neurobiology of Aging

Volumn 18, Issue 6, 1997, Pages 581-589

  Brining, Sheryl K ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Beta amyloid toxicity; Congo red; Peptide conformation

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED; TRYPAN BLUE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE DEGENERATION; PREDICTION; PRIORITY JOURNAL; SENILE PLAQUE; STAIN;

AMYLOID BETA-PROTEIN; ANIMALS; CELL DEATH; COLORING AGENTS; CONGO RED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; NEUROPEPTIDES; PC12 CELLS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROTEIN CONFORMATION; RATS;

EID: 0031471278     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00153-X     Document Type: Article

References (54)

1. Barrow C. J., Yasuda A., Kenny P. T. M., Zagorski M. G. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225:1992;1075-1093.
2. Barrow C. J., Zagorski M. G. Solution structures of β peptide and its constituent fragments Relation to amyloid deposition . Science. 253:1991;179-182.
3. Benditt E. P., Eriksen N., Berglund C. Congo red dichroism with dispersed amyloid fibrils, an extrinsic Cotton effect. Proc. Natl. Acad. Sci. USA. 66:1970;1044-1051.
4. Bertrand P., Burgevin M. C., Daniel N., Passat M., Dugat P., Dubois H., Clerc F., Doble A. Neurotoxicity of β amyloid peptides in rat primary hippocampal cultures. Soc. Neurosci. Abstr. 20:1994;601.
5. Beyreuther K., Dyrks T., Hilbich C., Mönning U., König G., Multhaup G., Pollwein P., Masters C. L. Down Syndrome and Alzheimer Disease. 1992;159-182 Wiley-Liss, New York.
6. Busciglio J., Lorenzo A., Yankner B. A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
7. Castaño E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A., Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein. Biochem. Biophys. Res. Comm. 141:1986;782-789.
8. Caughey B., Brown K., Raymond G. J., Katzenstein G. E., Thresher W. Binding of the protease-sensitive form of prion protein PrP (prion protein) to sulfated glycosaminoglycan and Congo red. J. Virol. 68:1994;2135-2141.
9. Caughey B., Dong A., Bhat K. S., Ernst D., Hayes S. F., Winslow W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochem. 30:1991;7672-7680.
10. Caughey B., Ernst D., Race R. E. Congo red inhibition of scrapie agent replication. J. Virol. 67:1993;6270-6272.
11. Caughey B., Race R. E. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59:1992;768-771.
12. Caughey B., Raymond G. J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:1993;643-650.
13. Elghetany M. T., Saleem A. Methods for staining amyloid in tissues A review . Stain Tech. 63:1988;201-212.
14. Elghetany M. T., Saleem A., Barr K. The Congo red stain revisited. Ann. Clin. Lab. Sci. 19:1989;190-195.
15. Elhaddaoui A., Pigorsch E., Delacourte A., Turrell S. Spectroscopic investigations of synthetic beta amyloid peptides of Alzheimer's disease. J. Mol. Struct. 347:1995;363-370.
16. Fukuyama R., Wadhwani K. C., Galdzicki Z., Rapoport S. I., Ehrenstein G. β-amyloid polypeptide increases calcium-uptake in PC12 cells A possible mechanism for its cellular toxicity in Alzheimer's disease . Brain Res. 667:1994;269-272.
17. Galdzicki Z., Fukuyama R., Wadhwani K. C., Rapoport S. I., Ehrenstein G. β-amyloid increases choline conductance of PC12 cells A possible mechanism of toxicity in Alzheimer's disease . Brain Res. 646:1994;332-336.
18. Gasset M., Baldwin M. A., Fletterick R. J., Prusiner S. B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA. 90:1993;1-5.
19. Glenner G. G., Eanes E. D., Bladen H. A., Linke R. P., Termine J. D. A comparison of native amyloid with synthetic protein fibrils. J. Histoch. Cytoch. 22:1974;1141-1158.
20. Glenner G. G., Eanes E. D., Page D. L. The relation of the properties of Congo red-stained amyloid fibrils to the β-conformation. J. Histoch. Cytoch. 20:1972;821-826.
21. Glenner G. G., Wong C. W. Alzheimer's disease Initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem. Biophys. Res. Comm. 120:1984;885-890.
22. Han H., Cho C.-G., Lansbury P. T. Jr. Technetium complexes for the quantitation of brain amyloid. J. Am. Chem. Soc. 118:1996;4506-4507.
23. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163.
24. Howlett D. R., Jennings K. H., Lee D. C., Clark M. S. G., Brown F., Wetzel R., Wood S. J., Camilleri P., Roberts G. W. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegen. 4:1995;23-32.
25. Kagan H. M., Hewitt N. A., Franzblau C. A microenvironmental probe of elastin, properties of a solubilized Congo red-elastin complex. Biochim. Biophys. Acta. 322:1973;258-268.
26. Kirschner D. A., Abraham C., Selkoe D. J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc. Natl. Acad. Sci. USA. 83:1986;503-507.
27. Klunk W. E., Debnath M. L., Pettegrew J. W. Development of small molecule probes for the beta-amyloid protein of Alzheimer' disease. Neurobiol. Aging. 15:1994;691-698.
28. Klunk W. E., Debnath M. L., Pettegrew J. W. Chrysamine-G binding to Alzheimer and control brain Autopsy study of a new amyloid probe . Neurobiol. Aging. 16:1995;541-548.
29. Klunk W. E., Pettegrew J. W., Abraham D. J. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histoch. Cytoch. 37:1989;1273-1281.
30. Is beta-amyloid neurotoxic? Kosik K., Coleman P. D. Neurobiol. Aging. 13:1992;535-625.
31. Lorenzo A., Yankner B. A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
32. Maggio J. E., Mantyh P. W. Brain amyloid - a physicochemical perspective. Brain Pathol. 6:1996;147-162.
33. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
34. May P. C., Gitter B. D., Waters D. C., Simmons L. K., Becker G. W., Small J. S., Robison P. M. β-amyloid peptide in vitro toxicity Lot-to-lot variability . Neurobiol. Aging. 13:1992;605-612.
35. Nguyen J. T., Baldwin M. A., Cohen F. E., Prusiner S. B. Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochem. 34:1995;4186-4192.
36. Patterson M. K. Jr. Measurement of growth and viability of cells in culture. Methods Enz. 58:1979;141-152.
37. Pollack S. J., Sadler I. I., Hawtin S. R., Tailor V. J., Shearman M. S. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells. Neurosci Lett. 184:1995;113-116.
38. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J. Clin. Invest. 47:1968;924-933.
39. Priola S. A., Caughey B. Inhibition of scrapie-associated PrP accumulation. Mol. Neurobiol. 8:1994;113-120.
40. Prusiner S. B. Biology and genetics of prion diseases. Ann. Rev. Microbiol. 48:1994;655-686.
41. Rogers J., Morrison J. H. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J. Neurosci. 5:1985;2801-2808.
42. Rozemuller J. M., Eikelenboom P., Stam F. C., Beyreuther K., Masters C. L. A4 protein in Alzheimer's disease Primary and secondary cellular events in extracellular amyloid deposition . J. Neuropath. Exp. Neurol. 48:1989;674-691.
43. Safar J., Roller P. P., Gadjusek D. C., Gibbs C. J. Jr. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Prot. Sci. 2:1993;2206-2216.
44. Selkoe D. J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
45. Shearman M. S., Ragan C. I., Iversen L. L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
46. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N., Li W. Y. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmac. 45:1994;373-379.
47. Soto C., Brañes M. C., Alvarez J., Inestrosa N. C. Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63:1994;1191-1198.
48. Taylor D. L., Allen R. D., Benditt E. P. Determination of the polarization optical properties of the amyloid-Congo red complex by phase modulation microspectrophotometry. J. Histoch. Cytoch. 22:1974;1105-1112.
49. Terry R. D., Gonatas N. K., Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44:1964;269-297.
50. Tomski S. J., Murphy R. M. Kinetics of aggregation of synthetic β-amyloid peptide. Arch. Biochem. Biophys. 294:1992;630-638.
51. Turnell W. G., Finch J. T. Binding of the dye Congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J. Mol. Biol. 227:1992;1205-1223.
52. Ueda K., Fukui Y., Kageyama H. Compromise of mitochondrial function induced by amyloid β protein in PC12 cells and protection by cyclic amp-dependent protein kinase inhibitors. Neurosci. Res. Comm. 15:1994;195-200.
53. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., Harigaya Y. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropath. 77:1988;113-119.
54. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid β protein Reversal by tachykinin neuropeptides . Science. 250:1990;279-282.